Correlation Between Inhibrx and Cannabis Suisse

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Inhibrx and Cannabis Suisse at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and Cannabis Suisse into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibrx and Cannabis Suisse Corp, you can compare the effects of market volatilities on Inhibrx and Cannabis Suisse and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of Cannabis Suisse. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and Cannabis Suisse.

Diversification Opportunities for Inhibrx and Cannabis Suisse

-0.5
  Correlation Coefficient

Very good diversification

The 3 months correlation between Inhibrx and Cannabis is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and Cannabis Suisse Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cannabis Suisse Corp and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with Cannabis Suisse. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cannabis Suisse Corp has no effect on the direction of Inhibrx i.e., Inhibrx and Cannabis Suisse go up and down completely randomly.

Pair Corralation between Inhibrx and Cannabis Suisse

Given the investment horizon of 90 days Inhibrx is expected to under-perform the Cannabis Suisse. But the stock apears to be less risky and, when comparing its historical volatility, Inhibrx is 32.88 times less risky than Cannabis Suisse. The stock trades about -0.03 of its potential returns per unit of risk. The Cannabis Suisse Corp is currently generating about 0.21 of returns per unit of risk over similar time horizon. If you would invest  1.00  in Cannabis Suisse Corp on August 29, 2024 and sell it today you would earn a total of  0.80  from holding Cannabis Suisse Corp or generate 80.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Inhibrx  vs.  Cannabis Suisse Corp

 Performance 
       Timeline  
Inhibrx 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Inhibrx are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating fundamental drivers, Inhibrx showed solid returns over the last few months and may actually be approaching a breakup point.
Cannabis Suisse Corp 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Cannabis Suisse Corp are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite fairly unfluctuating basic indicators, Cannabis Suisse demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Inhibrx and Cannabis Suisse Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Inhibrx and Cannabis Suisse

The main advantage of trading using opposite Inhibrx and Cannabis Suisse positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, Cannabis Suisse can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cannabis Suisse will offset losses from the drop in Cannabis Suisse's long position.
The idea behind Inhibrx and Cannabis Suisse Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Complementary Tools

Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Global Correlations
Find global opportunities by holding instruments from different markets